ࡱ> 8:71 Ybjbj 8*ЅqhЅqh T* * 8$<`````;;;RTTTTTT$c x;;;;;x``;R``R;RV@`LP׭ >0 F  $;;;;;;;xxaF;;;;;;; ;;;;;;;;;* X : Adverse Event (AE) Reporting Form Institutional Review Board (IRB) Principal Investigator: IRB Protocol #: Email Address: Phone Number: Extension: Project Title: Adverse Event (AE) Information: 1. Study Location (please check one): ( ( Other (List all sites involved): 2. Location of Adverse Event: ( ( Other: ___________________ 3. Seriousness of Event: ( Non-Serious ( Serious but not Life Threatening ( Life Threatening 4. Required Care: ( Emergency Room / Physician: ______________________________________ ( Clinic: ______________________________________ ( Counseling/Referral: ______________________________________ ( No additional care was sought ______________________________________ 5. Event Cause: In your judgment, how likely was the AE caused by the procedures in this protocol? ( Not related ( Unlikely ( Possibly ( Probably ( Definitely 6. Consent Form: Is the risk of this adverse event contained in your consent form? ( Yes ( No 7. Notification: Will participants currently enrolled in the study be notified of this event? ( Yes ( No Adverse Event Summary: Attach a detailed summary describing the circumstances of the adverse event. Include responses given by the subject and the investigator. If relevant, include procedures taken to prevent similar incidents. In your judgment, should the consent form or any portion of the study be revised as a result of this event? ( Yes. An application for continuing review will be submitted to the IRB indicating the nature of the amendment or modification within 10 days of receiving this adverse event reporting form. If an amendment is not received within 10 days, I understand that my protocol may be suspended. ( No. Although the event was possibly, probably or definitely caused by the study and the risk is not identified in the consent form, I do not wish to amend the protocol for the following reasons (use additional pages as needed). (please see reverse side) PI Certification: I certify that the adverse event information provided is accurate to the best of my knowledge. Further, I agree to submit a completed and original adverse event reporting form along with the required summary of events. ____________________________ _______________ Signature of Principal Investigator Date ___________________________________ ___________________ Signature of Supervising Faculty Member Date ________________________________________________________________________________________________________________________________ FOR IRB USE ONLY: Date Received: ______________     Revised 06/21/22 page 2 of 2 Revised 06/21/22 page 1 of 2 "C\]    & ' ( H I q r   7 8 H I n o V v w , - . /  3 4 > ] ^ j k 23 h]SCJ h]SCJ jh]SCJ h]SCJ h]SCJ h]SCJ h]SCJh]SR"C\]   & ' ( v.$00$d%d&d'dNOPQ]0^0a$ $00]0^0a$.$00$d%d&d'dNOPQ]0^0a$ 00]0^0 00]0^0 00]0^0 ( H I   V , - . /  > $00]0^0a$.$00$d%d&d'dNOPQ]0^0a$> j k ?@AB%$.$00$d%d&d'dNOPQ]0^0a$ $00]0^0a$.$00$d%d&d'dNOPQ]0^0a$39:?@AWB%$23;<=WijEFvw&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKL h]SCJ h]S6 h]SCJ h]S h]SCJ h]SCJ jh]SCJ h]SCJR<=WijEFv&'( |0]|^0+00$d%d&d'dNOPQ]0^0 $00]0^0a$0]0.$00$d%d&d'dNOPQ]0^0a$()*+,-./0123456789:;<=>?@ABCD |0]|^0DEFGHIJKL    2 $0]^0a$ 00]0^0 |]|^ |0]|^0     123<=CDEJKPQRSTUVWXYhhhhCJ hhCJhhjh]SUh]S h]SCJ h]SCJ+23QRSTUVWXY $0]^0a$ |0]|^0gdh 6&P1:ph/ =!"#$%@ x666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH66666666666666666666666666666666666666666666666666666666666666666p62&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666_HmH nH sH tH 8`8 Normal_HmH sH tH VV  Heading 1&$$8@&]^8`a$CJff  Heading 26$$00$d%d&d'd@&]0^0a$CJDA D Default Paragraph FontViV 0 Table Normal :V 44 la (k ( 0No List 4>@4 Title$a$5CJ:J@: Subtitle$a$5CJbT@b  Block Text0$00$d%d&d'd]0^0a$CJ4@"4 Header  !4 @24 Footer  !PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vj\{cp/IDg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½|SˌDإbj|E7C<bʼNpr8fnߧFrI.{1fVԅ$21(t}kJV1/ ÚQL×07#]fVIhcMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ] C:= ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j z'^9J{rJЃ3Ax| FU9…i3Q/B)LʾRPx)04N O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr Zy4Sw3?WӊhPxzSq]y Y >* /OQSV3Y ( > (D2Y 8@0(  B S  ?     0 1 W Z :EY a > D       2 W Z 33333   1 3 C D D E Q Z    1 3 C D D E Q Z zvx>Pfse2&1  ^`OJQJo(^`o(. ^`OJQJo(.z>se2h{?]S  @---Y @UnknownG.[x Times New Roman5Symbol3. .[x ArialeMonotype SortsSegoe UI SymbolC.,.{$ Calibri Light7..{$ CalibriA$BCambria Math#h߫G߫G'  !20 K@P  $Ph2!xxj( Initial Review ApplicationCSUWarren Sherman   Oh+'0 ( H T ` lxInitial Review ApplicationNormalWarren Sherman2Microsoft Office Word@G@\@ѭ@ѭ  ՜.+,0 hp    Initial Review Application Title  !"#$%&()*+,-.01234569Root Entry FLP׭;1Table WordDocument8*SummaryInformation('DocumentSummaryInformation8/CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q